New hope for diabetic eye disease: experimental drug SNP318 enters Mid-Stage trial
Disease control
Not yet recruiting
This study tests an experimental drug called SNP318 in 60 people with diabetic macular edema (DME), a condition that causes vision loss due to swelling in the retina. The goal is to see if the drug is safe and can improve vision or reduce swelling compared to a placebo. Participa…
Phase: PHASE2 • Sponsor: SciNeuro • Aim: Disease control
Last updated May 17, 2026 10:11 UTC